4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0001140361-16-049542
$IRDCIK 0001228627operating
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:33 PM ET
Size
7.6 KB
Accession
0001140361-16-049542
Insider Transaction Report
Form 4
Jeong Tae Heum
DirectorCFO
Transactions
- Award
Stock Option (right to buy)
2016-01-28+98,853→ 98,853 totalExercise: $0.35From: 2017-01-28Exp: 2026-01-28→ Common Stock (98,853 underlying) - Award
Stock Option (right to buy)
2016-01-28+100,000→ 100,000 totalExercise: $0.35Exp: 2026-01-28→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One quarter of the option vests and becomes exercisable on January 28, 2017, and thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month following such date until fully vested.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 4:33 PM ET
- Size
- 7.6 KB